TITLE

What's the point of rigorous research on complementary/alternative medicine?

AUTHOR(S)
Ernst, E.
PUB. DATE
April 2002
SOURCE
Journal of the Royal Society of Medicine;Apr2002, Vol. 95 Issue 4, p211
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article addresses eight common arguments against the application of the principles of science to complementary and alternative medicine (CAM). The eight arguments include "If it helps my patients, I don't need science to tell me that it works," "The nature of my therapy is such that it defies the clinical trial" and "Science destroys the very nature of CAM, so its application must be opposed."
ACCESSION #
23070429

 

Related Articles

  • Is Bigger Better? Wechsler, Jill // Pharmaceutical Executive;Oct2008, Vol. 28 Issue 10, p20 

    The article reports on the potential of larger pre-approval clinical studies as perceived by several medical researchers and analysts. According to an analyst, the pre-approval clinical trials sometimes may be worth the time and money involved in the studies. Moreover, Duke University School of...

  • Complementary medicine: state of the evidence. Vincent, Charles; Furnham, Adrian // Journal of the Royal Society of Medicine;Apr1999, Vol. 92 Issue 4, p170 

    The article provides a broad overview of research on complementary medicine. It focuses on studies of efficacy of the major therapies and to potential adverse effects, so that clinicians may make informed decisions when discussing such issues with their patients. Information regarding mechanism...

  • What do patients want from medical research? Fox, Robin // Journal of the Royal Society of Medicine;Jun1996, Vol. 89 Issue 6, p301 

    The article comments on the patients' views concerning medical research. Both patients and their relatives want research on better ways to live with ill-health. There have been barriers of language and culture even when consumers have been consulted on the design and end-points of trials. The...

  • Researching complementary and alternative treatments -- the gatekeepers are not at home. Fonnebø, Vinjar; Grimsgaard, Sameline; Walach, Harald; Ritenbaugh, Cheryl; Norheim, Arne Johan; MacPherson, Hugh; Lewith, George; Launsø, Laila; Koithan, Mary; Falkenberg, Torkel; Boon, Heather; Aickin, Mikel // BMC Medical Research Methodology;2007, Vol. 7, p7 

    Background: To explore the strengths and weaknesses of conventional biomedical research strategies and methods as applied to complementary and alternative medicine (CAM), and to suggest a new research framework for assessing these treatment modalities. Discussion: There appears to be a gap...

  • Update on Treatment of Arthritis in Children. Lovell, Daniel J. // Bulletin of the NYU Hospital for Joint Diseases;2006, Vol. 64 Issue 1/2, p72 

    Although improved in recent years, the outcome for children who have juvenile idiopathic arthritis (JIA) is still less than ideal. Between 25% and 70% of children with JIA will still have active arthritis 10 years after disease onset, and over 40% will enter adulthood with active arthritis....

  • Stakeholders Dialogue with National Center for Complementary Medicine. Gahles, Nancy; Quirk, Tina // Homeopathy Today;Sep/Oct2007, Vol. 27 Issue 5, p6 

    The article takes a look on CAM research in the U.S. It is stated that conventional researchers have sought to impose upon CAM research the criteria and methods of randomized controlled clinical trials (RCT). It reveals that it is designed to test safety, dosage, and efficacy of an individual...

  • Assessing Efficacy of Complementary Medicine: Adding Qualitative Research Methods to the "Gold Standard" Verhoef, Marja J.; Casebeer, Ann L.; Hilsden, Robert J. // Journal of Alternative & Complementary Medicine;Jun2002, Vol. 8 Issue 3, p275 

    Randomized controlled trials (RCTs) have an important place in the assessment of the efficacy of complementary and alternative medicine (CAM). However, they address only one, limited, question, namely whether an intervention has—statistically—an effect. They do not address why the...

  • Vision Disorders and Phosphodiesterase Type 5 Inhibitors. Laties, Alan M. // Drug Safety;2009, Vol. 32 Issue 1, p1 

    Phosphodiesterase type 5 (PDE-5) inhibitors (sildenafil, vardenafil and tadalafil) have been in widespread use for the safe and effective treatment of erectile dysfunction (ED) for nearly a decade. During that time, a relatively small number of patients have experienced adverse visual events,...

  • The future is made of royal jelly. Selby, Mary // GP: General Practitioner;6/9/2006, p20 

    The article offers information about alternative therapy. A general practitioner suggested that alternative therapy should be used in spite of it being placebo. The author is making a room for the biorhythm probe in her consulting room to use another therapy. Drug companies are suppressing the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics